Immunodiagnostic Systems acquires Italian firm

Boldon-based Immunodiagnostic Systems Holdings PLC (IDS) has acquired Italian company Diametra

Immunodiagnostic Systems
Immunodiagnostic Systems

The Boldon-based Immunodiagnostic Systems Holdings PLC (IDS) has acquired an Italian company

Diametra, which specialises in the development and commercialisation of manual immunoenzymatic assays, is based in Spello, Umbria, and employs approximately 25 staff.

In the year-ended December 31, 2013, it generated revenues of €3.3m and an EBIT of €0.3m.

The acquisition is in line with the IDS’ strategy of building its presence as a leading solution provider for speciality testing.

In particular, it augments the group’s endocrinology pipeline and provides it with additional development and manufacturing capabilities.

Patrik Dahlen, chief executive of IDS, said: “We are delighted to have secured the acquisition of Diametra, which will assist in the acceleration of our strategic plan outlined earlier this year.

“In particular, Diametra will provide immediate access to endocrinology manual assays in the area of steroid hormones that can be converted to automated assays for our iSYS instrument.

“We continue to pursue complementary acquisitions that will help us grow our specialist endocrinology menu and build operational excellence.”


David Whetstone
Culture Editor
Graeme Whitfield
Business Editor
Mark Douglas
Newcastle United Editor
Stuart Rayner
Sports Writer